A nomogram for predicting survival of head and neck mucosal melanoma

HIGHLIGHTS

• who: Qing-Qing Xu from the The study workflow is displayed in Fig1. From March , to November, three hundred patients diagnosed with MMHN at our hospital were included in the primary cohort. MMHN patients from March , to December , were chosen as the validation cohort. The inclusion criteria for all the patients were previously untreated, nonmetastatic, and newly histologically confirmed stage III-IVB MMHN. All the patients were restaged according to the, th edition American Joint Committee on Cancer (AJCC) staging system for MMHN [12]. The TNM classification was based on surgical documents, pathological features and imaging findings . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.